Guest Column: Patient Input Is A Must - Even Under Time and Money Constraints December 4, 2025 - Clinical Leader
A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases November 28, 2025 - ACRopenrheumatology
How Social Media and AI Are Transforming Clinical Trial Recruitmen November 6, 2025 - BlackDoctor.org
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus November 5, 2025 - Arthritis Care & Research
I Thought It Was Acne. Turns Out, It Was Lupus. November 5, 2025 - allure
Signs of Chronic Inflammation: Common and Surprising Symptoms November 5, 2025 - Everyday Health
Positive Phase III Data for Genentech’s Gazyva Show Significant Reduction in Disease Activity for Systemic Lupus Erythematosus November 3, 2025 - Genentech Press Release
Signs of Chronic Inflammation: November 1, 2025 - Everyday Health
Reviewing Lupus Research From the 2025 ACR Meeting October 30, 2025
FDA Approves Gazyva for Lupus Nephritis in Adults October 20, 2025 - Managed Healthcare Executive
Podcast: Lupus Clinical Development Enters A New Era Of Innovation October 20, 2025 - In Vivo
Podcast: Lupus Clinical Development Enters a New Era of Innovation October 20, 2025 - InVivo
Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus October 17, 2025 - AstraZeneca Press Release
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease October 17, 2025 - New England Journal of MedicineReported on in the professional publication Medscape
CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for lupus nephritis October 16, 2025 - Roche Press Release
Exercise and Pain: How to Move No Matter How Much You Hurt October 13, 2025 - WebMD
Hinge Bio Announces FDA Clearance of Investigational New Drug Application for HB2198, a Novel B cell-Depleting Agent, for Patients with Systemic Lupus Erythematosus and Lupus Nephritis October 13, 2025 - Hinge Bio Press Release
A Woman’s Guide to Self-Advocacy for Autoimmune Disease Care October 10, 2025 - HealthCentral
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis October 7, 2025 - Adicet Bio Press Release
Vie Ventures Convenes Inaugural Therapeutics Advisory Council to Advance Collaboration Among Autoimmune Disease Ecosystems September 18, 2025 - Vie Ventures Press Release
Saphnelo self-administration TULIP-SC Phase III trial meets primary endpoint in patients with systemic lupus erythematosus based on an interim analysis September 17, 2025 - AstraZeneca Press Release
Hinge Bio Expands Leadership Team to Drive Clinical Development of GEM-DIMER™ Programs and Announces Publication in Scientific Reports September 5, 2025 - Hinge Bio Press Release
Lupus Reimagined: Targeting the Cause, Not Just the Symptoms August 14, 2025 - Drug Target Review
Systemic Lupus Treatment: Skin Disease History Insights July 16, 2025 - NEWSYLIST
Veteran Venture Capitalists Launch Autoimmune Firm Vie Ventures July 9, 2025 - Fierce Biotech
Vie Ventures, New Life Sciences Venture Capital Firm, Launches to Advance Next Generation Therapies for Autoimmune Diseases July 9, 2025 - Vie Ventures Press Release
More Data Back CAR T-Cell Therapy for Lupus, With Promise of Wider Availability June 13, 2025 - MedPage Today
Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025 June 12, 2025 - Merck Press Release
Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity June 12, 2025 - UCB and Biogen Press Release
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress June 11, 2025 - Fate Therapeutics Press Release
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress June 11, 2025 - Cabaletta Bio Press Release
Cullinan Therapeutics Licenses Rights to Velinotamig, a Clinical-Stage BCMA-Directed Bispecific T Cell Engager, from Genrix Bio for Development in Autoimmune Diseases June 6, 2025 - Cullinan Therapeutics Press Release
‘Symptom Invalidation’ in Clinically Uncertain Diagnoses Can Leave Lasting Mental Health Harms Featuring LT PAL Jiwa Farrell June 5, 2025 - Medscape
B Cell-Depleting Therapy in SLE & Lupus Nephritis June 4, 2025 - The Rheumatologist
Do SGLT2 and GLP-1 therapies have a role in Lupus? June 3, 2025 - RheumNow
Long-Term Anifrolumab Use Improves Quality of Life in Lupus May 29, 2025 - Medscape
Driving Nonprofit-Enabled R&D Acceleration for Lupus: Q&A with Albert T. Roy May 27, 2025 - Pharmaceutical Executive
Ventus Therapeutics to Present Phase 1 Results for VENT-03, a First-in-Class cGAS Inhibitor, at LUPUS 2025 May 23, 2025 - Ventus Therapeutics Press Release
EMD Serono Presents Positive Ph 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in CLE and SLE with Active Lupus Rash May 21, 2025 - EMD Serono Press Release
Patient-centric trials: progress but gaps remain, with Stacie Bell, PhD May 20, 2025 - Clinical Trials Arena
LuCIN Investigator Presents Research on B-Cell Targeting Therapies in Lupus May 6, 2025 - Healio
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402 April 21, 2025 - Immunovant Press Release
To Be or Not to Be - the Role of B-Cell Depletion Editorial April 17, 2025 - New England Journal of Medicine
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis April 17, 2025 - New England Journal of Medicine
Beware This Cruel Mystery Disease That Can Permanently Damage Organs April 14, 2025 - New York Post
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE) April 14, 2025 - Fate Therapeutics Press Release
Gut Health: Dr. Gregg Silverman of NYU Grossman School of Medicine On What Gut Health Is, Why It’s So Important And How To Optimize It April 8, 2025 - Authority Magazine
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma April 8, 2025 - Allogene Therapeutics Press Release
FDA Accepts Supplemental Biologics License Application for Genentech’s Gazyva for the Treatment of Lupus Nephritis March 5, 2025 - Genentech Press Release
LuCIN Chair Comments on New Study March 3, 2025 - United Press International
Study: Misdiagnosis of lupus symptoms linked to mental health, trust issues March 3, 2025 - United Press International
CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in a Patient with Autoimmune Disease | Morningstar February 28, 2025 - CARsgen Press Release
Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls February 20, 2025 - Annals of the Rheumatic Diseases
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings :: Cabaletta Bio, Inc. (CABA) February 18, 2025 - Cabaletta Bio Press Release
Royalty Pharma Announces R&D Funding Collaboration with Biogen February 12, 2025 - Royalty Pharma Press Release
Stronger Together: How Lupus Warriors Are Shaping the Future February 3, 2025 - BlackDoctor.org
Foodborne Illness Is a Threat— Especially if You Have an Autoimmune Disease January 31, 2025 - HealthCentral.com
7 Clinical Trial Misconceptions Every Lupus Patient Should Know January 30, 2025 - BlackDoctor.org
Doctors Dismissed Her Symptoms—Then She Collapsed at a Work Conference January 30, 2025 - BlackDoctor.org
Leveling Up: Cell Therapy Research Expands Horizons in Autoimmune Disease December 31, 2024 - HCP LiveFree registration required
Life with Lupus: Stacey Kennedy-Conner on Advocacy and Empowerment December 30, 2024 - The Educated Patient
Interview: Daniel Wallace - European Medical Journal December 13, 2024 - European Medical Journal
How the PALS Program Empowers Patients with Lupus, with Stacie Bell, Ph.D. December 4, 2024 - The Educated Patient
Natural Killer Cell Therapy: An “Off-the-Shelf” Option for Severe and Refractory SLE? November 19, 2024 - MedCentral
Living with Lupus: “It May Look Different, But Life Goes On” November 7, 2024 - BlackDoctor.org
A Black Doctor Shares Why Lupus Trials Need REAL Representation October 30, 2024 - BlackDoctor.org
Why Are Lupus Clinical Trials So Challenging? August 13, 2024 - Clinical Leader
Poor Neighborhood, More Than Race, Predicts Greater Lupus Skin Severity July 25, 2024 - Medpage Today
Doctors Recommend These Self-Care Practices For People Living With The Autoimmune Disease June 8, 2024 - Woman’s World
Halsey reveals she has lupus and a rare blood-cell disorder. Here's what to know. June 6, 2024 - Yahoo Life!  
Lupus Therapeutics, Artiva team up on AlloNK Phase 1 trial March 1, 2024 - Lupus News Today
Stacie Bell, PhD: The Effect of Cognitive Impairment on Daily Life in Patients with SLE December 26, 2023 - HCP Live
Stacie Bell, PhD: Adverse Childhood Experiences in Pediatric SLE December 24, 2023 - HCP Live
Stacie Bell, PhD: Differences in Perceived Executive Function Between Parents, Children with SLE December 22, 2023 - HCP Live
Rheumatology Month in Review: November 2023 December 3, 2023 - HCP Live
Stacie Bell, PhD: Lupus Therapeutics and AbbVie to Join Forces for Promising Lupus Treatment Program November 2, 2023 - HCP Live
Lupus Therapeutics, AbbVie team up for Phase 3 trial of upadacitinib October 26, 2023 - upus News Today
AbbVie and Lupus Therapeutics partner for SLE trial recruitment October 25, 2023 - Clinical Trials Arena
Advancing Diversity in Lupus Research Through Community-Based Program, Awards August 2, 2023 - HCP Live
LRA Launches Initiatives to Increase Diversity in Lupus Research August 1, 2023 - HCP Live
Lupus Research Alliance to Combat Underrepresentation of Black patients in Lupus Trials July 18, 2023 - Healio
Lupus Therapeutics Announces Three Phase 3 Clinical Trials Testing New Therapies for SLE and Lupus Nephritis June 2, 2023 - News-Medical Life Sciences
Lupus Landmark Study Launched to Improve Research, Personalized Care June 1, 2023 - Lupus News Today
Launching the Lupus Landmark Study will advance individualized treatment for lupus patients June 1, 2023 - Rheuma TV
Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients May 24, 2023 - News-Medical
Lupus Research Alliance Announces Largest Prospective Study of SLE, New Patient Registry May 23, 2023 - Healio
Lupus Landmark Study Aims for Personalized Medicine Goals May 23, 2023 - Medscape
Lupus Research Alliance (LRA) is Pleased to Announce the appointment of Stacie J. Bell, PhD as Executive Vice President January 18, 2023 - Rheum Now